EMIT II Plus LSD Assay
The EMIT II LSD Assay is intended for the qualitative and semiquantitative determination of lysergic acid diethylamide in human urine at a cutoff level of 0.5 ng/mL.
EMIT II Plus LSD Assay
Accurately detect lysergic acid diethylamide
Features & Benefits
LSD is the most potent and studied hallucinogen. It disrupts normal brain functioning by affecting serotonin, producing vivid hysterical behavior. Flashbacks are a recurrence of the hallucinations that can occur weeks, months, or even years after the last dose.
The EMIT II LSD Assay provides:
- High sensitivity to major LSD metabolites
- Excellent precision—all within-lab (total) CVs ≤0.6% or less across the assay range
- 98% correlation with reference method (RIA)
Applications are available for the Viva-Jr®, Viva-E®, Viva-ProE®, V-Twin® drug testing systems and AU® Series analyzers.
Technical Specifications
EMIT II Plus LSD Assay Performance
Assay Principle | Homogeneous Enzyme Multiplied Immonoassay (EMIT) |
Cut-off | 0.5 ng/mL |
Sample | Urine |
Reagent Stability | Unopened: until expiration date. Onboard instrument: up to 4 weeks |
Calibration Frequency | As indicated by control results |